Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration
IntroductionWe assessed mortality and losses to follow‐up (LTFU) during adolescence in routine care settings in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.MethodsCohorts in the Asia‐Pacific, the Caribbean, Central, and South America, and sub‐Saharan Africa (Central,...
Gespeichert in:
| Veröffentlicht in: | Journal of the International AIDS Society 2018-12, Vol.21 (12) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 12 |
| container_start_page | |
| container_title | Journal of the International AIDS Society |
| container_volume | 21 |
| creator | Kariminia, Azar Law, Matthew Davies, Mary‐Ann Vinikoor, Michael Wools‐Kaloustian, Kara Leroy, Valeriane Edmonds, Andrew McGowan, Catherine Vreeman, Rachel Fairlie, Lee Ayaya, Samuel Yotebieng, Marcel Takassi, Elom Pinto, Jorge Adedimeji, Adebola Malateste, Karen Machado, Daisy M Penazzato, Martina Hazra, Rohan Sohn, Annette H |
| description | IntroductionWe assessed mortality and losses to follow‐up (LTFU) during adolescence in routine care settings in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.MethodsCohorts in the Asia‐Pacific, the Caribbean, Central, and South America, and sub‐Saharan Africa (Central, East, Southern, West) contributed data, and included adolescents living with HIV (ALHIV) enrolled from January 2003 and aged 10 to 19 years (period of adolescence) while under care up to database closure (June 2016). Follow‐up started at age 10 years or the first clinic visit, whichever was later. Entering care at |
| doi_str_mv | 10.1002/jia2.25215 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2290169409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2290169409</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1049-d0325f9f2f02fe7c89c48568bb3762464dd27a3c3cacbd14b6596029590eb7203</originalsourceid><addsrcrecordid>eNpNkEFOwzAURC0EEqWw4QSW2CGl2D-xEy-rUmikIjbANnIcp3XlxsV2qbrjCJyRk5BSFqzmazSar3kIXVMyooTA3cpIGAEDyk7QgOasSIAzOP13n6OLEFaEcCgyMUDuyfkorYl7LLsGWxeCDjg63Dpr3e7782u7wXLtugWWjbM6KN3FgK35ML21M3GJZ-UbNh2OS41Lje-nY7ywrpYWK7fsy3uxVtbOy2hcd4nOWmmDvvrTIXp9mL5MZsn8-bGcjOeJoiQTSUNSYK1ooSXQ6lwVQmUF40VdpzmHjGdNA7lMVaqkqhua1ZwJTkAwQXSdA0mH6ObYu_HufatDrFZu67v-ZQUgCOUiI6JP3R5TyvfDvW6rjTdr6fcVJdUBaHUAWv0CTX8AgrZpZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290169409</pqid></control><display><type>article</type><title>Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration</title><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kariminia, Azar ; Law, Matthew ; Davies, Mary‐Ann ; Vinikoor, Michael ; Wools‐Kaloustian, Kara ; Leroy, Valeriane ; Edmonds, Andrew ; McGowan, Catherine ; Vreeman, Rachel ; Fairlie, Lee ; Ayaya, Samuel ; Yotebieng, Marcel ; Takassi, Elom ; Pinto, Jorge ; Adedimeji, Adebola ; Malateste, Karen ; Machado, Daisy M ; Penazzato, Martina ; Hazra, Rohan ; Sohn, Annette H</creator><creatorcontrib>Kariminia, Azar ; Law, Matthew ; Davies, Mary‐Ann ; Vinikoor, Michael ; Wools‐Kaloustian, Kara ; Leroy, Valeriane ; Edmonds, Andrew ; McGowan, Catherine ; Vreeman, Rachel ; Fairlie, Lee ; Ayaya, Samuel ; Yotebieng, Marcel ; Takassi, Elom ; Pinto, Jorge ; Adedimeji, Adebola ; Malateste, Karen ; Machado, Daisy M ; Penazzato, Martina ; Hazra, Rohan ; Sohn, Annette H ; on behalf of IeDEA</creatorcontrib><description>IntroductionWe assessed mortality and losses to follow‐up (LTFU) during adolescence in routine care settings in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.MethodsCohorts in the Asia‐Pacific, the Caribbean, Central, and South America, and sub‐Saharan Africa (Central, East, Southern, West) contributed data, and included adolescents living with HIV (ALHIV) enrolled from January 2003 and aged 10 to 19 years (period of adolescence) while under care up to database closure (June 2016). Follow‐up started at age 10 years or the first clinic visit, whichever was later. Entering care at <15 years was a proxy for perinatal infection, while entering care ≥15 years represented infection acquired during adolescence. Competing risk regression was used to assess associations with death and LTFU among those ever receiving triple‐drug antiretroviral therapy (triple‐ART).ResultsOf the 61,242 ALHIV from 270 clinics in 34 countries included in the analysis, 69% (n = 42,138) entered care <15 years of age (53% female), and 31% (n = 19,104) entered care ≥15 years (81% female). During adolescence, 3.9% died, 30% were LTFU and 8.1% were transferred. For those with infection acquired perinatally versus during adolescence, the four‐year cumulative incidences of mortality were 3.9% versus 5.4% and of LTFU were 26% versus 69% respectively (both p < 0.001). Overall, there were higher hazards of death for females (adjusted sub‐hazard ratio (asHR) 1.19, 95% confidence interval (CI) 1.07 to 1.33), and those starting treatment at ≥5 years of age (highest asHR for age ≥15: 8.72, 95% CI 5.85 to 13.02), and in care in mostly urban (asHR 1.40, 95% CI 1.13 to 1.75) and mostly rural settings (asHR 1.39, 95% CI 1.03 to 1.87) compared to urban settings. Overall, higher hazards of LTFU were observed among females (asHR 1.12, 95% CI 1.07 to 1.17), and those starting treatment at age ≥5 years (highest asHR for age ≥15: 11.11, 95% CI 9.86 to 12.53), in care at district hospitals (asHR 1.27, 95% CI 1.18 to 1.37) or in rural settings (asHR 1.21, 95% CI 1.13 to 1.29), and starting triple‐ART after 2006 (highest asHR for 2011 to 2016 1.84, 95% CI 1.71 to 1.99).ConclusionsBoth mortality and LTFU were worse among those entering care at ≥15 years. ALHIV should be evaluated apart from younger children and adults to identify population‐specific reasons for death and LTFU.</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1002/jia2.25215</identifier><language>eng</language><publisher>Geneva: John Wiley & Sons, Inc</publisher><subject>Acquired immune deficiency syndrome ; Age ; AIDS ; Child development ; Collaboration ; Health care ; HIV ; Hospitals ; Human immunodeficiency virus ; Mortality ; Preventive medicine ; Teenagers</subject><ispartof>Journal of the International AIDS Society, 2018-12, Vol.21 (12)</ispartof><rights>2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1049-d0325f9f2f02fe7c89c48568bb3762464dd27a3c3cacbd14b6596029590eb7203</citedby><cites>FETCH-LOGICAL-c1049-d0325f9f2f02fe7c89c48568bb3762464dd27a3c3cacbd14b6596029590eb7203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Kariminia, Azar</creatorcontrib><creatorcontrib>Law, Matthew</creatorcontrib><creatorcontrib>Davies, Mary‐Ann</creatorcontrib><creatorcontrib>Vinikoor, Michael</creatorcontrib><creatorcontrib>Wools‐Kaloustian, Kara</creatorcontrib><creatorcontrib>Leroy, Valeriane</creatorcontrib><creatorcontrib>Edmonds, Andrew</creatorcontrib><creatorcontrib>McGowan, Catherine</creatorcontrib><creatorcontrib>Vreeman, Rachel</creatorcontrib><creatorcontrib>Fairlie, Lee</creatorcontrib><creatorcontrib>Ayaya, Samuel</creatorcontrib><creatorcontrib>Yotebieng, Marcel</creatorcontrib><creatorcontrib>Takassi, Elom</creatorcontrib><creatorcontrib>Pinto, Jorge</creatorcontrib><creatorcontrib>Adedimeji, Adebola</creatorcontrib><creatorcontrib>Malateste, Karen</creatorcontrib><creatorcontrib>Machado, Daisy M</creatorcontrib><creatorcontrib>Penazzato, Martina</creatorcontrib><creatorcontrib>Hazra, Rohan</creatorcontrib><creatorcontrib>Sohn, Annette H</creatorcontrib><creatorcontrib>on behalf of IeDEA</creatorcontrib><title>Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration</title><title>Journal of the International AIDS Society</title><description>IntroductionWe assessed mortality and losses to follow‐up (LTFU) during adolescence in routine care settings in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.MethodsCohorts in the Asia‐Pacific, the Caribbean, Central, and South America, and sub‐Saharan Africa (Central, East, Southern, West) contributed data, and included adolescents living with HIV (ALHIV) enrolled from January 2003 and aged 10 to 19 years (period of adolescence) while under care up to database closure (June 2016). Follow‐up started at age 10 years or the first clinic visit, whichever was later. Entering care at <15 years was a proxy for perinatal infection, while entering care ≥15 years represented infection acquired during adolescence. Competing risk regression was used to assess associations with death and LTFU among those ever receiving triple‐drug antiretroviral therapy (triple‐ART).ResultsOf the 61,242 ALHIV from 270 clinics in 34 countries included in the analysis, 69% (n = 42,138) entered care <15 years of age (53% female), and 31% (n = 19,104) entered care ≥15 years (81% female). During adolescence, 3.9% died, 30% were LTFU and 8.1% were transferred. For those with infection acquired perinatally versus during adolescence, the four‐year cumulative incidences of mortality were 3.9% versus 5.4% and of LTFU were 26% versus 69% respectively (both p < 0.001). Overall, there were higher hazards of death for females (adjusted sub‐hazard ratio (asHR) 1.19, 95% confidence interval (CI) 1.07 to 1.33), and those starting treatment at ≥5 years of age (highest asHR for age ≥15: 8.72, 95% CI 5.85 to 13.02), and in care in mostly urban (asHR 1.40, 95% CI 1.13 to 1.75) and mostly rural settings (asHR 1.39, 95% CI 1.03 to 1.87) compared to urban settings. Overall, higher hazards of LTFU were observed among females (asHR 1.12, 95% CI 1.07 to 1.17), and those starting treatment at age ≥5 years (highest asHR for age ≥15: 11.11, 95% CI 9.86 to 12.53), in care at district hospitals (asHR 1.27, 95% CI 1.18 to 1.37) or in rural settings (asHR 1.21, 95% CI 1.13 to 1.29), and starting triple‐ART after 2006 (highest asHR for 2011 to 2016 1.84, 95% CI 1.71 to 1.99).ConclusionsBoth mortality and LTFU were worse among those entering care at ≥15 years. ALHIV should be evaluated apart from younger children and adults to identify population‐specific reasons for death and LTFU.</description><subject>Acquired immune deficiency syndrome</subject><subject>Age</subject><subject>AIDS</subject><subject>Child development</subject><subject>Collaboration</subject><subject>Health care</subject><subject>HIV</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Mortality</subject><subject>Preventive medicine</subject><subject>Teenagers</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpNkEFOwzAURC0EEqWw4QSW2CGl2D-xEy-rUmikIjbANnIcp3XlxsV2qbrjCJyRk5BSFqzmazSar3kIXVMyooTA3cpIGAEDyk7QgOasSIAzOP13n6OLEFaEcCgyMUDuyfkorYl7LLsGWxeCDjg63Dpr3e7782u7wXLtugWWjbM6KN3FgK35ML21M3GJZ-UbNh2OS41Lje-nY7ywrpYWK7fsy3uxVtbOy2hcd4nOWmmDvvrTIXp9mL5MZsn8-bGcjOeJoiQTSUNSYK1ooSXQ6lwVQmUF40VdpzmHjGdNA7lMVaqkqhua1ZwJTkAwQXSdA0mH6ObYu_HufatDrFZu67v-ZQUgCOUiI6JP3R5TyvfDvW6rjTdr6fcVJdUBaHUAWv0CTX8AgrZpZQ</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Kariminia, Azar</creator><creator>Law, Matthew</creator><creator>Davies, Mary‐Ann</creator><creator>Vinikoor, Michael</creator><creator>Wools‐Kaloustian, Kara</creator><creator>Leroy, Valeriane</creator><creator>Edmonds, Andrew</creator><creator>McGowan, Catherine</creator><creator>Vreeman, Rachel</creator><creator>Fairlie, Lee</creator><creator>Ayaya, Samuel</creator><creator>Yotebieng, Marcel</creator><creator>Takassi, Elom</creator><creator>Pinto, Jorge</creator><creator>Adedimeji, Adebola</creator><creator>Malateste, Karen</creator><creator>Machado, Daisy M</creator><creator>Penazzato, Martina</creator><creator>Hazra, Rohan</creator><creator>Sohn, Annette H</creator><general>John Wiley & Sons, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201812</creationdate><title>Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration</title><author>Kariminia, Azar ; Law, Matthew ; Davies, Mary‐Ann ; Vinikoor, Michael ; Wools‐Kaloustian, Kara ; Leroy, Valeriane ; Edmonds, Andrew ; McGowan, Catherine ; Vreeman, Rachel ; Fairlie, Lee ; Ayaya, Samuel ; Yotebieng, Marcel ; Takassi, Elom ; Pinto, Jorge ; Adedimeji, Adebola ; Malateste, Karen ; Machado, Daisy M ; Penazzato, Martina ; Hazra, Rohan ; Sohn, Annette H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1049-d0325f9f2f02fe7c89c48568bb3762464dd27a3c3cacbd14b6596029590eb7203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Age</topic><topic>AIDS</topic><topic>Child development</topic><topic>Collaboration</topic><topic>Health care</topic><topic>HIV</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Mortality</topic><topic>Preventive medicine</topic><topic>Teenagers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kariminia, Azar</creatorcontrib><creatorcontrib>Law, Matthew</creatorcontrib><creatorcontrib>Davies, Mary‐Ann</creatorcontrib><creatorcontrib>Vinikoor, Michael</creatorcontrib><creatorcontrib>Wools‐Kaloustian, Kara</creatorcontrib><creatorcontrib>Leroy, Valeriane</creatorcontrib><creatorcontrib>Edmonds, Andrew</creatorcontrib><creatorcontrib>McGowan, Catherine</creatorcontrib><creatorcontrib>Vreeman, Rachel</creatorcontrib><creatorcontrib>Fairlie, Lee</creatorcontrib><creatorcontrib>Ayaya, Samuel</creatorcontrib><creatorcontrib>Yotebieng, Marcel</creatorcontrib><creatorcontrib>Takassi, Elom</creatorcontrib><creatorcontrib>Pinto, Jorge</creatorcontrib><creatorcontrib>Adedimeji, Adebola</creatorcontrib><creatorcontrib>Malateste, Karen</creatorcontrib><creatorcontrib>Machado, Daisy M</creatorcontrib><creatorcontrib>Penazzato, Martina</creatorcontrib><creatorcontrib>Hazra, Rohan</creatorcontrib><creatorcontrib>Sohn, Annette H</creatorcontrib><creatorcontrib>on behalf of IeDEA</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kariminia, Azar</au><au>Law, Matthew</au><au>Davies, Mary‐Ann</au><au>Vinikoor, Michael</au><au>Wools‐Kaloustian, Kara</au><au>Leroy, Valeriane</au><au>Edmonds, Andrew</au><au>McGowan, Catherine</au><au>Vreeman, Rachel</au><au>Fairlie, Lee</au><au>Ayaya, Samuel</au><au>Yotebieng, Marcel</au><au>Takassi, Elom</au><au>Pinto, Jorge</au><au>Adedimeji, Adebola</au><au>Malateste, Karen</au><au>Machado, Daisy M</au><au>Penazzato, Martina</au><au>Hazra, Rohan</au><au>Sohn, Annette H</au><aucorp>on behalf of IeDEA</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration</atitle><jtitle>Journal of the International AIDS Society</jtitle><date>2018-12</date><risdate>2018</risdate><volume>21</volume><issue>12</issue><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>IntroductionWe assessed mortality and losses to follow‐up (LTFU) during adolescence in routine care settings in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.MethodsCohorts in the Asia‐Pacific, the Caribbean, Central, and South America, and sub‐Saharan Africa (Central, East, Southern, West) contributed data, and included adolescents living with HIV (ALHIV) enrolled from January 2003 and aged 10 to 19 years (period of adolescence) while under care up to database closure (June 2016). Follow‐up started at age 10 years or the first clinic visit, whichever was later. Entering care at <15 years was a proxy for perinatal infection, while entering care ≥15 years represented infection acquired during adolescence. Competing risk regression was used to assess associations with death and LTFU among those ever receiving triple‐drug antiretroviral therapy (triple‐ART).ResultsOf the 61,242 ALHIV from 270 clinics in 34 countries included in the analysis, 69% (n = 42,138) entered care <15 years of age (53% female), and 31% (n = 19,104) entered care ≥15 years (81% female). During adolescence, 3.9% died, 30% were LTFU and 8.1% were transferred. For those with infection acquired perinatally versus during adolescence, the four‐year cumulative incidences of mortality were 3.9% versus 5.4% and of LTFU were 26% versus 69% respectively (both p < 0.001). Overall, there were higher hazards of death for females (adjusted sub‐hazard ratio (asHR) 1.19, 95% confidence interval (CI) 1.07 to 1.33), and those starting treatment at ≥5 years of age (highest asHR for age ≥15: 8.72, 95% CI 5.85 to 13.02), and in care in mostly urban (asHR 1.40, 95% CI 1.13 to 1.75) and mostly rural settings (asHR 1.39, 95% CI 1.03 to 1.87) compared to urban settings. Overall, higher hazards of LTFU were observed among females (asHR 1.12, 95% CI 1.07 to 1.17), and those starting treatment at age ≥5 years (highest asHR for age ≥15: 11.11, 95% CI 9.86 to 12.53), in care at district hospitals (asHR 1.27, 95% CI 1.18 to 1.37) or in rural settings (asHR 1.21, 95% CI 1.13 to 1.29), and starting triple‐ART after 2006 (highest asHR for 2011 to 2016 1.84, 95% CI 1.71 to 1.99).ConclusionsBoth mortality and LTFU were worse among those entering care at ≥15 years. ALHIV should be evaluated apart from younger children and adults to identify population‐specific reasons for death and LTFU.</abstract><cop>Geneva</cop><pub>John Wiley & Sons, Inc</pub><doi>10.1002/jia2.25215</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1758-2652 |
| ispartof | Journal of the International AIDS Society, 2018-12, Vol.21 (12) |
| issn | 1758-2652 1758-2652 |
| language | eng |
| recordid | cdi_proquest_journals_2290169409 |
| source | Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Acquired immune deficiency syndrome Age AIDS Child development Collaboration Health care HIV Hospitals Human immunodeficiency virus Mortality Preventive medicine Teenagers |
| title | Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T05%3A04%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mortality%20and%20losses%20to%20follow%E2%80%90up%20among%20adolescents%20living%20with%20HIV%20in%20the%20Ie%20DEA%20global%20cohort%20collaboration&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Kariminia,%20Azar&rft.aucorp=on%20behalf%20of%20IeDEA&rft.date=2018-12&rft.volume=21&rft.issue=12&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1002/jia2.25215&rft_dat=%3Cproquest_cross%3E2290169409%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2290169409&rft_id=info:pmid/&rfr_iscdi=true |